Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.
Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).
The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.
Publications found:
1,310
Sort by:
Indian Bioinformatics Market Forecast to 2015
US$ 500.00
Bioinformatics is one of the fastest emerging interdisciplinary research areas, which may be defined as an ‘interface between biological and computational sciences’. Most of the Bioinformatics work ca...
April 2012
35 pages
EPO Biosimilars Market Forecast to 2015
US$ 300.00
The biosimilars industry has been growing stupendously across the globe for the past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivi...
April 2012
34 pages
G-CSF Biosimilars Market Forecast to 2015
US$ 300.00
For the past few years, the biosimilars industry has been growing stupendously across the globe due to increasing healthcare costs and rising aging population. It is expected to evolve, to a great ext...
April 2012
35 pages
HGH Biosimilars Market Forecast to 2015
US$ 300.00
Across the globe, the biosimilars industry has been growing stupendously for the past few years. Increasing healthcare costs and rising aging population are driving the industry that is expected to ev...
April 2012
35 pages
Lupin - Generic Fortamet Launched At Last, However Low Competition Window Shrinks
US$ 140.00
We withdraw our Positive Investment Alert (PIA) on Lupin after it re-launched generic Fortamet ($83m of annual US sales) in the US market. We issued ... the Preliminary Injunction (PI) on Lupin’s generic Fortamet. While we expected Lupin to launch it soon after the ruling, Lupin waited for the Federal Circuit ...
April 2012
3 pages
Merck - Celltrion filed first mAB Biosimilar in Europe: Remicade Challenged
US$ 90.00
Celltrion filed infliximab biosimilar (CT-P13) in Europe and was accepted for review by EMA. It is the first biosimilar mAb to be filed for approval in Europe. The patent ... Celltrion conducted PhI and PhIII clinical trials with the duration of 12 months in more than 850 patients. It has already filed Infliximab ...
April 2012
1 pages
Biotechnology Reagents: Market Research Report
US$ 4,500.00
... analyzes the worldwide markets for Biotechnology Reagents in US$ Million by the following Product Segments: Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis ... Diagnostics Ltd., Siemens Healthcare Diagnostics, Inc., and Sigma - Aldrich. Market data and analytics are derived from primary and secondary ...
March 2012
925 pages
Branded Generics in South East Asia: Current and Future Opportunities
US$ 945.00
... launching their branded generic brands but I can't say for sure that success is guaranteed in South East Asia.” – Dr. Suchitra Kataria, former Head of Business Development and In-Licensing - Regional Strategic Development Asia Pacific at Bayer ...
March 2012
78 pages
Generics as a Vehicle to Improve Market Access
US$ 695.00
In low and middle-income countries, around 17.6 million people each year die of treatable infectious diseases, reproductive health issues, and childhood illnesses. Millions more experience poor qualit...
March 2012
79 pages
Assessment of the Japan Generics Industry
US$ 800.00
Executive
While Japan is the second largest pharma market globally, it has a very low penetration rate of generic drugs. The country’s government has set an ambitious goal to enhance the generic...
March 2012
25 pages
Moving Bed Bioreactor (MBBR): Market Research Report
US$ 4,600.00
This report analyzes the worldwide markets for Moving Bed Bioreactor (MBBR) in US$ Million by the following End-Use Applications: Municipal, Food and ... Water Solutions & Technologies, Wock-Oliver, Inc., and World Water Works, Inc. Market data and analytics are derived from primary and secondary research. ...
February 2012
222 pages
Global Biosimilars Market Forecast to 2015
US$ 1,500.00
The biosimilars industry has been growing stupendously across the globe for past few years. Increasing healthcare costs and rising aging population are driving the industry, which stands at a vivid po...
February 2012
140 pages
Generic Defence Strategies: Targeting Patient Co-Pay
US$ 695.00
Coupons for co-pays are fast becoming a standard part of the brand marketer’s toolkit, due to proven positive ROI. It’s projected that by 2017, coupons will be associated with 30% of all U.S. prescrip...
February 2012
41 pages
Japan Generics Market Analysis
US$ 1,000.00
Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare expens...
February 2012
55 pages
Canada’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis
US$ 175.00
... is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ... the world’s citizens. Aruvian's R'search analyzes the Canadian Biotechnology industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in ...
February 2012
20 pages
Japan’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis
US$ 175.00
... is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes ... the world’s citizens. Aruvian's R'search analyzes the Japanese Biotechnology Industry in the Michael Porter’s Five Forces Analysis. It uses concepts developed in ...
February 2012
20 pages
Looking at Bioinformatics – IT’s Human Touch
US$ 275.00
... ranging industries and research applications. The growing acceptance of Bioinformatics as an important field requiring focused commercial support and ... in order to expand the service bases. Aruvian's R'search’s report – Looking at Bioinformatics – IT’s Human Touch - is a analytical docket on the Bio Informatics ...
February 2012
85 pages
Competitor Analysis: Anti-Obesity Peptides and Biologics
US$ 262.00
... peptides and biologics as of February 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and ... . In addition, the report lists company-specific R&D pipelines of anti-obesity peptides and biologics. Competitor projects are listed in a tabular format providing ...
February 2012
28 pages
LUPIN - Generic Tricor To Offer a Cushion Against Suprax Generic Erosion
US$ 140.00
... multiple years. In addition, there is a strong likelihood that Lupin may remain the only generic player for some time – something that we have ... for Suprax from FY13 to FY14 and (2) estimating $40m from generic Tricor in FY14 (to be launched in Q4 FY13). We upgrade our target price to Rs.463 by applying ...
January 2012
6 pages
European Biotechnology Directory 2012 - 2013
US$ 200.00
PDF version is dispatched within twenty-four hours after the purchase. PDF option available starting May, 20 The European Directory of Biotechnology Companies 2012-13 is one of the most comprehensive...
January 2012
USA Biotechnology Directory 2012 - 2013
US$ 200.00
PDF version is dispatched within twenty-four hours after the purchase. The most comprehensive and accurate Directory of companies and executives in the USA biotechnology industry.
January 2012
Genetic Engineering: Market Research Report
US$ 1,995.00
The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers an aerial ... discussions in the report are punctuated with fact-rich market data tables. Regional markets elaborated upon include United States, Canada, India, ...
December 2011
118 pages
Biotechnology: Market Research Report
US$ 1,450.00
The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird’s eye view of the Biotechnology industry. Annotated with 21 fact, and data rich tables the report offers a ...
December 2011
281 pages
US Biotech Market Analysis
US$ 1,000.00
The US represents the world’s largest biotechnology market, leading with its innovation, extensive R&D, and regular company developments in various spheres of the biotechnology sector. On the back...
December 2011
65 pages
Outlook 2012 - Mature Biotech - Investing in Growth and Value buys!
US$ 2,000.00
... ’ in 2011! We expect a similar trend of acquisitions and in-licensing of better molecules in 2012 and beyond, as MB companies have robust cash flow to further leverage ... Gilead (GILD) are our Top Picks for FY2012 in the Mature Biotech Sector. BIIB’s focus and leadership in the MS market and positive ...
December 2011
46 pages
Assessment of the fast growing Indian Biotech Market
US$ 800.00
... The country is a favored destination in custom research outsourcing and custom manufacturing outsourcing (CMO). Growth in the sector is likely to come from India's strong position in biosimilars, molecular diagnostics and personalized medicine. However, the industry is also facing various challenges such as ...
November 2011
30 pages
Mature Biotech: 3Q11 Earnings Summary
US$ 90.00
In this note we summarize the 3Q earnings of Mature Biotech – ALXN, AMGN, BIIB, CELG, GILD, and ONXX. We continue to reiterate ... PhIII data in mCRC). For more details, please read our 3Q11 earnings’ summary report released on 4th Nov, 2011 on “Mature Biotech: 3Q11 Earnings Summary”.
November 2011
5 pages
Booming Biotech Market in India
US$ 800.00
Indian biotech sector is witnessing a quantum surge in terms of growth of the industry. The growth can be attributed to a large pool of scientific talent, world-class information technology industry,...
October 2011
100 pages
2012 Biomet Company Profile & Analysis: Biologics Division
US$ 2,995.00
... also expanded into areas such as sports medicine and dental medical devices. Biomet's key joint reconstruction business unit accounted for the bulk of ... medicine and small joint reconstructive surgery were two of the fastest-growing areas for Biomet, both of which continued multi-year trends. However Biomet’s ...
October 2011
64 pages
Membrane Bioreactors: Market Research Report
US$ 4,500.00
This report analyzes the worldwide markets for Membrane Bioreactors in US$ Million by the following End-Use Segments: Municipal, and Industrial. The ... Corporation, Siemens Water Technologies, Toray Industries, Inc., and Veolia Environnement. Market data and analytics are derived from primary and secondary ...
October 2011
312 pages
Therapeutic Monoclonal Antibodies: World Market 2011-2021
US$ 2,635.00
... and three research interviews (see the table of contents). Therapeutic Monoclonal Antibodies: World Market 2011-2021 shows you opportunities, challenges and ... pipeline trends Investigate competition and opportunities influencing the industry and market Find out what will stimulate and restrain the industry ...
September 2011
166 pages
Biobanks: Market Research Report
US$ 4,200.00
This report analyzes the worldwide markets for Biobanks in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and ... ., NEXUS Biosystems, REMP AG, Qiagen NV, TAP Biosystems, ThemoGenesis, and Thermo Scientific. Market data and analytics are derived from primary and secondary ...
September 2011
532 pages
Biochips: Genosensors, Microarrays, Labs-On-The-Chip
US$ 680.00
Global PDF: US$ 1,900.00 Highlights Biochips, DNA Chips, Genosensors, Microarrays and Labs-on-the-Chip are extensions of biosensor and DNA technologies. ... cost issues continue to complicate their routine use. The report also discusses diagnostic value of biochips, which may not be realized until genetic ...
August 2011
15 pages
Genetic Diseases and Pharmacogenomics
US$ 720.00
Global PDF: US$ 1,900.00 This report presents: Overview of the clinical significance and market needs for major genetic diseases Reviews the field of pharmacogenomics Provides listings of companies developing and marketing NAT technologies and products. Contains 75 pages
August 2011
75 pages
Biomarkers: Market Research Report
US$ 4,800.00
... and Others (miRNA Analysis and Others). The total market is also analyzed by the following Application Areas: Biomarker Discovery, Clinical Drug Development, and ... , Inc., Rules-Based Medicine, Inc., and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary ...
August 2011
1305 pages
Global Biosimilars Market Analysis
US$ 1,400.00
Single User PDF Format: US$ 1,400.00
Multi-User License: US$ 1,800.00
Hard Copy: US$ 1,500.00
CD-ROM: US$ 1,500.00 The global biosimilars industry has been growing stupendously since t...
July 2011
65 pages
China Monoclonal Antibody Industry Report, 2010-2011
US$ 1,700.00
China has been engaging in the R&D of monoclonal antibody industry for a long time, but still lags far behind the European and American countries in terms of industrialization. In 2010, the market...
July 2011
64 pages
Asia Pacific Biotechnology Market (2008-2012)
US$ 1,600.00
Single User PDF Format: US$ 1,600.00 Multi-User License: US$ 2,400.00 Hard Copy: US$ 1,800.00 CD-ROM: US$ 1,800.00The Asia Pacific biotechnology market is one with immense potential, which can be tap...
June 2011
165 pages
Orthopedic Biomaterials, The World Market
US$ 3,995.00
Price (Single User PDF): US$ 3,995.00 Price (Global Site License): US$ 7,995.00 Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fractur...
May 2011
250 pages
Future of White Biotechnology in China
US$ 14,897.00
... Analysis on the development bottleneck and investment opportunities of White Biotechnology in China will be more detailed. Analysis on bio-fuels and ... and development environments of China’s White Biotechnology will be more detailed. SWOT analysis on analysis of China’s white biotechnology will more detailed. ...
May 2011
288 pages
Brazil Biomaterial Market (2010 – 2015)
US$ 5,650.00
... Brazil biomaterial market. Plus, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the biomaterials market ...
May 2011
179 pages
Global Biomaterial Market (2010 - 2015)
US$ 5,650.00
... biomaterials is expected to reach $64.7 billion in 2015 from $25.6 billion in 2008 with a CAGR of 15% from 2010 to 2015. In 2010, the orthopedic biomaterial market recorded revenues of $12 billion or 37.5% of the total global biomaterial market ... , at a CAGR of 12.7% (2010 to 2015) because the market is relatively mature compared to other product markets. Cardiovascular biomaterial is the second-highest market, and contributed 36.1% to the global biomaterial market in 2010. With the ...
May 2011
417 pages
